Cerus (CERS) Cash from Operations Growth (1y) (2011 - 2026)
Cerus (CERS) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.85 Bn | 176.55 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.55 Bn | 99.33 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | -84.38% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 185.96% |
| 7 | GE HealthCare Technologies | 28.15 Bn | 25.87 Bn | 1.98 Bn | 16.00% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.75 Bn | 21.63 Bn | 2.07 Bn | 122.43% |
| 10 | Cerus | 604.75 Mn | 524.33 Mn | 27.89 Mn | -261.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -261.26% |
| Dec 31, 2025 | 25.79% |
| Sep 30, 2025 | -52.65% |
| Jun 30, 2025 | -709.98% |
| Mar 31, 2025 | -143.08% |
| Dec 31, 2024 | 132.46% |
| Sep 30, 2024 | 138.80% |
| Jun 30, 2024 | 104.46% |
| Mar 31, 2024 | 123.05% |
| Dec 31, 2023 | -764.64% |
| Sep 30, 2023 | -409.67% |
| Jun 30, 2023 | -2,507.54% |
| Mar 31, 2023 | 60.38% |
| Dec 31, 2022 | -43.70% |
| Sep 30, 2022 | 68.73% |
| Jun 30, 2022 | 96.02% |
| Mar 31, 2022 | -22.92% |
| Dec 31, 2021 | 86.27% |
| Sep 30, 2021 | -26.85% |
| Jun 30, 2021 | -9.40% |